Why You're Still Hungry on Wegovy 1.7mg

Is it normal to feel hungry at 1.7mg, or is something wrong?

It's completely normal. Wegovy's titration schedule exists for a reason: each dose step (0.25mg, 0.5mg, 1.0mg, 1.7mg) is designed to let your body adjust gradually rather than hitting the therapeutic ceiling all at once. The NHS's patient guidance on semaglutide confirms that 2.4mg is the standard maintenance dose where the medicine does most of its appetite-regulation work.

At 1.7mg, many people notice their appetite is noticeably reduced compared with where they started, but still present in a way that feels frustrating. That's not a failure. Semaglutide slows gastric emptying and acts on GLP-1 receptors in the brain to reduce hunger signals, and those effects become more pronounced as the dose rises. Think of 1.7mg as the last training lap before the race pace. Most people find the step to 2.4mg is when hunger quietens significantly.

If you feel absolutely no change from your pre-treatment appetite, that's worth flagging to your prescriber rather than waiting. It could indicate the dose needs to progress sooner, or that something about your routine is counteracting the medicine. You can read more about how Wegovy's dose schedule works and what each step is designed to achieve.

What can make hunger worse at this dose?

Several practical factors can make the 1.7mg stage feel harder than it needs to be. Meal composition matters more on semaglutide than many people expect. Low-protein meals empty from the stomach quickly, leaving you hungry again faster. High-glycaemic foods cause blood-sugar swings that the medicine doesn't fully offset at this dose. And skipping meals altogether (which some people do, hoping to speed weight loss) can backfire by triggering stronger hunger signals later in the day.

Hydration is another overlooked factor. Thirst and hunger signals overlap in the brain, and mild dehydration is common on GLP-1 treatment, partly because the medicine can reduce your drive to drink as well as eat. Aiming for consistent fluid intake through the day tends to take the edge off the residual appetite many people feel at 1.7mg.

Sleep quality and stress both influence hunger hormones independent of semaglutide. If you're sleeping poorly or under significant pressure, the medicine has more to compete with. These aren't reasons to stop or change your dose, they're things worth addressing alongside treatment. Our page on Wegovy and how it works covers the physiological picture in more detail.

Does the hunger ease when you move to 2.4mg?

For the majority of people, yes. The step from 1.7mg to 2.4mg is where most users report the clearest shift in appetite, the point at which eating becomes something they have to remember rather than something they're driven toward. The STEP 1 trial, published in the New England Journal of Medicine, found that participants on 2.4mg semaglutide achieved an average weight reduction of around 15% over 68 weeks, a result that depends heavily on the appetite suppression the maintenance dose delivers.

That said, a small proportion of people do still feel meaningful hunger at 2.4mg. If that's the case after several weeks on the maintenance dose, it's worth discussing with your prescriber whether the hunger at 2.4mg reflects a dosing question or a lifestyle factor. Progression to the recently approved 7.2mg dose exists as an option, but that's a clinical decision made on evidence, not something to assume will be the next step.

In the meantime, keep a simple note of when hunger strikes: time of day, last meal, stress level. Patterns in that log often tell a prescriber more than a single snapshot appointment.

Should you contact your prescriber, or just wait it out?

If you're around two to three weeks into 1.7mg and hunger is noticeably better than at baseline (even if it hasn't gone completely) waiting for the four-week mark and progressing as scheduled is usually the right call. The medicine hasn't finished settling at this dose yet.

Contact your prescriber sooner if: hunger is no better than before you started treatment; you're feeling consistently unwell alongside the hunger (nausea, vomiting, fatigue that isn't settling); or you're worried the treatment is simply not working for you. A prescriber can check whether your pen technique, storage and timing are all correct, an injection given incorrectly or a pen stored outside its temperature range can reduce effectiveness. Pens should live in the fridge, not in a warm gym bag or a bathroom cabinet, until you're ready to use them. If this pattern sounds familiar from an earlier point in your treatment, our guide on still feeling hungry on the 0.25mg starting dose explores why appetite can persist in the early weeks and what that means for your progress.

For a broader look at what affects how Wegovy feels day to day, the Wegovy 1.7mg guide covers this dose in full. And if you're thinking about what the treatment costs at each stage of the journey, our Wegovy pricing page lays out what's included in a private prescription. When you're ready to speak to a clinician about your next step, starting a free consultation with our prescribers is the place to begin.